Samuel Nash

Samuel Nash is currently an Associate Principal Scientist at AstraZeneca, where they lead pharmaceutical science activities for small molecule oncology and neuroscience drug discovery projects. Previously, they served as a Senior Scientist and Scientist at AstraZeneca and worked as an ADME Scientist at Charles River Laboratories, performing validated assays and generating reports tailored to client needs. Samuel’s academic background includes a Master’s degree in Chemistry from the University of York and research experience as an Organic Research Scientist at the University of Sydney, where they conducted experiments and wrote a thesis on polycyclic ethers.